公司推出开放源码平台,分享10 000名病人的肺癌遗传数据。 Companies launch open-source platform to share lung cancer genetics data from 10,000 patients.

23andMe、Troper Wojcicki慈善社和Lifibit公司为肺癌遗传学研究启动了一个开放源数据平台。 23andMe, Troper Wojcicki Philanthropies, and Lifebit have launched an open-source data platform for lung cancer genetics research. 这项研究的目标是到2027年登记10 000名肺癌病人,使研究人员能够通过Lifebit的平台免费获得已查明的数据。 The study aims to enroll 10,000 lung cancer patients by 2027, offering researchers free access to de-identified data through Lifebit's platform. 该倡议旨在打破数据障碍,加快肺癌遗传学研究进展。 This initiative seeks to break down data barriers and speed up research progress in lung cancer genetics.